REV3L Antibody - #AF0342
製品: | REV3L Antibody |
カタログ: | AF0342 |
タンパク質の説明: | Rabbit polyclonal antibody to REV3L |
アプリケーション: | WB IHC |
反応性: | Human, Mouse |
予測: | Pig, Zebrafish, Bovine, Sheep, Rabbit, Dog, Chicken, Xenopus |
分子量: | 352kDa; 353kD(Calculated). |
ユニプロット: | O60673 |
RRID: | AB_2834178 |
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# AF0342, RRID:AB_2834178.
折りたたみ/展開
Catalytic subunit of DNA polymerase zeta; Polymerase DNA zeta; POLZ; RAD54 like; REV3 yeast homolog like; Sez4; Yeast homolog of Rev 3;
免疫原
- O60673 REV3L_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MFSVRIVTADYYMASPLQGLDTCQSPLTQAPVKKVPVVRVFGATPAGQKTCLHLHGIFPYLYVPYDGYGQQPESYLSQMAFSIDRALNVALGNPSSTAQHVFKVSLVSGMPFYGYHEKERHFMKIYLYNPTMVKRICELLQSGAIMNKFYQPHEAHIPYLLQLFIDYNLYGMNLINLAAVKFRKARRKSNTLHATGSCKNHLSGNSLADTLFRWEQDEIPSSLILEGVEPQSTCELEVDAVAADILNRLDIEAQIGGNPGLQAIWEDEKQRRRNRNETSQMSQPESQDHRFVPATESEKKFQKRLQEILKQNDFSVTLSGSVDYSDGSQEFSAELTLHSEVLSPEMLQCTPANMVEVHKDKESSKGHTRHKVEEALINEEAILNLMENSQTFQPLTQRLSESPVFMDSSPDEALVHLLAGLESDGYRGERNRMPSPCRSFGNNKYPQNSDDEENEPQIEKEEMELSLVMSQRWDSNIEEHCAKKRSLCRNTHRSSTEDDDSSSGEEMEWSDNSLLLASLSIPQLDGTADENSDNPLNNENSRTHSSVIATSKLSVKPSIFHKDAATLEPSSSAKITFQCKHTSALSSHVLNKEDLIEDLSQTNKNTEKGLDNSVTSFTNESTYSMKYPGSLSSTVHSENSHKENSKKEILPVSSCESSIFDYEEDIPSVTRQVPSRKYTNIRKIEKDSPFIHMHRHPNENTLGKNSFNFSDLNHSKNKVSSEGNEKGNSTALSSLFPSSFTENCELLSCSGENRTMVHSLNSTADESGLNKLKIRYEEFQEHKTEKPSLSQQAAHYMFFPSVVLSNCLTRPQKLSPVTYKLQPGNKPSRLKLNKRKLAGHQETSTKSSETGSTKDNFIQNNPCNSNPEKDNALASDLTKTTRGAFENKTPTDGFIDCHFGDGTLETEQSFGLYGNKYTLRAKRKVNYETEDSESSFVTHNSKISLPHPMEIGESLDGTLKSRKRRKMSKKLPPVIIKYIIINRFRGRKNMLVKLGKIDSKEKQVILTEEKMELYKKLAPLKDFWPKVPDSPATKYPIYPLTPKKSHRRKSKHKSAKKKTGKQQRTNNENIKRTLSFRKKRSHAILSPPSPSYNAETEDCDLNYSDVMSKLGFLSERSTSPINSSPPRCWSPTDPRAEEIMAAAEKEAMLFKGPNVYKKTVNSRIGKTSRARAQIKKSKAKLANPSIVTKKRNKRNQTNKLVDDGKKKPRAKQKTNEKGTSRKHTTLKDEKIKSQSGAEVKFVLKHQNVSEFASSSGGSQLLFKQKDMPLMGSAVDHPLSASLPTGINAQQKLSGCFSSFLESKKSVDLQTFPSSRDDLHPSVVCNSIGPGVSKINVQRPHNQSAMFTLKESTLIQKNIFDLSNHLSQVAQNTQISSGMSSKIEDNANNIQRNYLSSIGKLSEYRNSLESKLDQAYTPNFLHCKDSQQQIVCIAEQSKHSETCSPGNTASEESQMPNNCFVTSLRSPIKQIAWEQKQRGFILDMSNFKPERVKPRSLSEAISQTKALSQCKNRNVSTPSAFGEGQSGLAVLKELLQKRQQKAQNANTTQDPLSNKHQPNKNISGSLEHNKANKRTRSVTSPRKPRTPRSTKQKEKIPKLLKVDSLNLQNSSQLDNSVSDDSPIFFSDPGFESCYSLEDSLSPEHNYNFDINTIGQTGFCSFYSGSQFVPADQNLPQKFLSDAVQDLFPGQAIEKNEFLSHDNQKCDEDKHHTTDSASWIRSGTLSPEIFEKSTIDSNENRRHNQWKNSFHPLTTRSNSIMDSFCVQQAEDCLSEKSRLNRSSVSKEVFLSLPQPNNSDWIQGHTRKEMGQSLDSANTSFTAILSSPDGELVDVACEDLELYVSRNNDMLTPTPDSSPRSTSSPSQSKNGSFTPRTANILKPLMSPPSREEIMATLLDHDLSETIYQEPFCSNPSDVPEKPREIGGRLLMVETRLANDLAEFEGDFSLEGLRLWKTAFSAMTQNPRPGSPLRSGQGVVNKGSSNSPKMVEDKKIVIMPCKCAPSRQLVQVWLQAKEEYERSKKLPKTKPTGVVKSAENFSSSVNPDDKPVVPPKMDVSPCILPTTAHTKEDVDNSQIALQAPTTGCSQTASESQMLPPVASASDPEKDEDDDDNYYISYSSPDSPVIPPWQQPISPDSKALNGDDRPSSPVEELPSLAFENFLKPIKDGIQKSPCSEPQEPLVISPINTRARTGKCESLCFHSTPIIQRKLLERLPEAPGLSPLSTEPKTQKLSNKKGSNTDTLRRVLLTQAKNQFAAVNTPQKETSQIDGPSLNNTYGFKVSIQNLQEAKALHEIQNLTLISVELHARTRRDLEPDPEFDPICALFYCISSDTPLPDTEKTELTGVIVIDKDKTVFSQDIRYQTPLLIRSGITGLEVTYAADEKALFHEIANIIKRYDPDILLGYEIQMHSWGYLLQRAAALSIDLCRMISRVPDDKIENRFAAERDEYGSYTMSEINIVGRITLNLWRIMRNEVALTNYTFENVSFHVLHQRFPLFTFRVLSDWFDNKTDLYRWKMVDHYVSRVRGNLQMLEQLDLIGKTSEMARLFGIQFLHVLTRGSQYRVESMMLRIAKPMNYIPVTPSVQQRSQMRAPQCVPLIMEPESRFYSNSVLVLDFQSLYPSIVIAYNYCFSTCLGHVENLGKYDEFKFGCTSLRVPPDLLYQVRHDITVSPNGVAFVKPSVRKGVLPRMLEEILKTRFMVKQSMKAYKQDRALSRMLDARQLGLKLIANVTFGYTSANFSGRMPCIEVGDSIVHKARETLERAIKLVNDTKKWGARVVYGDTDSMFVLLKGATKEQSFKIGQEIAEAVTATNPKPVKLKFEKVYLPCVLQTKKRYVGYMYETLDQKDPVFDAKGIETVRRDSCPAVSKILERSLKLLFETRDISLIKQYVQRQCMKLLEGKASIQDFIFAKEYRGSFSYKPGACVPALELTRKMLTYDRRSEPQVGERVPYVIIYGTPGVPLIQLVRRPVEVLQDPTLRLNATYYITKQILPPLARIFSLIGIDVFSWYHELPRIHKATSSSRSEPEGRKGTISQYFTTLHCPVCDDLTQHGICSKCRSQPQHVAVILNQEIRELERQQEQLVKICKNCTGCFDRHIPCVSLNCPVLFKLSRVNRELSKAPYLRQLLDQF
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - O60673 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
Y68 | Phosphorylation | Uniprot | |
Y128 | Phosphorylation | Uniprot | |
S142 | Phosphorylation | Uniprot | |
K188 | Ubiquitination | Uniprot | |
S435 | Phosphorylation | Uniprot | |
S449 | Phosphorylation | Uniprot | |
S470 | Phosphorylation | Uniprot | |
S545 | Phosphorylation | Uniprot | |
T582 | Phosphorylation | Uniprot | |
S583 | Phosphorylation | Uniprot | |
S654 | Phosphorylation | Uniprot | |
K704 | Ubiquitination | Uniprot | |
K834 | Acetylation | Uniprot | |
K836 | Acetylation | Uniprot | |
T850 | Phosphorylation | Uniprot | |
S852 | Phosphorylation | Uniprot | |
T853 | Phosphorylation | Uniprot | |
K924 | Acetylation | Uniprot | |
T929 | Phosphorylation | Uniprot | |
S932 | Phosphorylation | Uniprot | |
S934 | Phosphorylation | Uniprot | |
K960 | Acetylation | Uniprot | |
S968 | Phosphorylation | Uniprot | |
K970 | Acetylation | Uniprot | |
S1030 | Phosphorylation | Uniprot | |
T1033 | Phosphorylation | Uniprot | |
T1041 | Phosphorylation | Uniprot | |
S1075 | Phosphorylation | O96017 (CHEK2) | Uniprot |
S1114 | Phosphorylation | Uniprot | |
T1118 | Phosphorylation | Uniprot | |
S1123 | Phosphorylation | Uniprot | |
S1124 | Phosphorylation | Uniprot | |
S1130 | Phosphorylation | Uniprot | |
Y1156 | Phosphorylation | Uniprot | |
S1185 | Phosphorylation | Uniprot | |
K1263 | Ubiquitination | Uniprot | |
S1281 | Phosphorylation | Uniprot | |
K1410 | Ubiquitination | Uniprot | |
K1504 | Acetylation | Uniprot | |
K1582 | Acetylation | Uniprot | |
T1589 | Phosphorylation | Uniprot | |
S1603 | Phosphorylation | Uniprot | |
K1693 | Ubiquitination | Uniprot | |
S1724 | Phosphorylation | Uniprot | |
S1796 | Phosphorylation | Uniprot | |
S1967 | Phosphorylation | Uniprot | |
K1978 | Ubiquitination | Uniprot | |
T2028 | Phosphorylation | Uniprot | |
S2038 | Phosphorylation | Uniprot | |
S2056 | Phosphorylation | Uniprot | |
S2146 | Phosphorylation | Uniprot | |
S2147 | Phosphorylation | Uniprot | |
S2171 | Phosphorylation | Uniprot | |
S2183 | Phosphorylation | Uniprot | |
S2220 | Phosphorylation | Uniprot | |
K2251 | Ubiquitination | Uniprot | |
T2259 | Phosphorylation | Uniprot | |
T2298 | Phosphorylation | Uniprot | |
T2363 | Phosphorylation | Uniprot | |
Y2378 | Phosphorylation | Uniprot | |
K2508 | Ubiquitination | Uniprot | |
S2522 | Phosphorylation | Uniprot | |
K2822 | Acetylation | Uniprot | |
T2831 | Phosphorylation | Uniprot | |
K2853 | Ubiquitination | Uniprot | |
K2868 | Methylation | Uniprot | |
T2936 | Phosphorylation | Uniprot | |
Y2937 | Phosphorylation | Uniprot | |
Y2984 | Phosphorylation | Uniprot | |
Y2985 | Phosphorylation | Uniprot | |
K3087 | Ubiquitination | Uniprot |
研究背景
Catalytic subunit of the DNA polymerase zeta complex, an error-prone polymerase specialized in translesion DNA synthesis (TLS). Lacks an intrinsic 3'-5' exonuclease activity and thus has no proofreading function.
Nucleus.
Ubiquitously expressed.
Heterodimer with MAD2L2. This dimer forms the minimal DNA polymerase zeta complex (Pol-zeta2), with REV3L bearing DNA polymerase catalytic activity, although its activity is very low in this context. Component of the tetrameric Pol-zeta complex (Pol-zeta4), which consists of REV3L, MAD2L2, POLD2 and POLD3; Pol-zeta4 is the fully active form of DNA polymerase zeta.
Its C-terminal part could serve as the catalytic domain during nucleotide polymerization, while its N-terminal part could provide sites for protein-protein interactions with other factors during translesion DNA synthesis.
The CysB motif binds 1 4Fe-4S cluster and is required for the formation of polymerase complexes.
Belongs to the DNA polymerase type-B family.
研究領域
· Genetic Information Processing > Replication and repair > Fanconi anemia pathway.
· Human Diseases > Drug resistance: Antineoplastic > Platinum drug resistance.
· Metabolism > Global and overview maps > Metabolic pathways.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.